Kanzen Capital Corp. (Kanzen) and Geyser Management Inc. (Geyser) announced that Health Canada has granted Geyser’s wholly owned subsidiary, 0957102 B.C. Ltd. (“0975”), a producer
Date of Initial Licensing 2018-10-16
Wholesale Distributors/Retailers Plants / Seeds

0957102 B.C. Ltd.

Kanzen Capital Corp. (Kanzen) and Geyser Management Inc. (Geyser) announced that Health Canada has granted Geyser’s wholly owned subsidiary, 0957102 B.C. Ltd. (“0975”), a producer’s licence to cultivate (the Licence). The Licence has a term of three years. Cultivation is planned to commence imminently. 0957 has an approved 8,000 sq. ft. facility in Port Coquitlam, B.C., dedicated to the manufacturing and planned distribution of cannabis and cannabisinfused cosmetics and functional foods. The facility also houses a product formulation and R&D innovation centre. Using proprietary nanotechnology formulations and manufacturing processes, formulations will deliver superior efficacy and bioavailability. Leveraging Canada’s leadership in cannabis and its international reputation for quality, the company will be building conditions based brands into global leaders.










 

Related Listing